These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38962490)

  • 1. Effectiveness and Safety of Different Estradiol Regimens in Transgender Females: A Randomized Controlled Trial.
    Cortez S; Moog D; Lewis C; Williams K; Herrick CJ; Fields ME; Gray T; Guo Z; Nicol G; Baranski T
    J Endocr Soc; 2024 Jul; 8(8):bvae108. PubMed ID: 38962490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial.
    Cortez S; Moog D; Lewis C; Williams K; Herrick C; Fields M; Gray T; Guo Z; Nicol G; Baranski T
    JMIR Res Protoc; 2023 Dec; 12():e53092. PubMed ID: 38133914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults.
    Cirrincione LR; Winston McPherson G; Rongitsch J; Sadilkova K; Drees JC; Krasowski MD; Dickerson JA; Greene DN
    LGBT Health; 2021; 8(2):125-132. PubMed ID: 33439749
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
    Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
    BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal Treatment of Transgender Women with Oral Estradiol.
    Leinung MC; Feustel PJ; Joseph J
    Transgend Health; 2018; 3(1):74-81. PubMed ID: 29756046
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum Hormone Concentrations in Transgender Youth Receiving Estradiol.
    Sumerwell C; Carlin K; Walsh E; Hodax JK
    Endocr Pract; 2024 Feb; 30(2):155-159. PubMed ID: 38029927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial.
    Burinkul S; Panyakhamlerd K; Suwan A; Tuntiviriyapun P; Wainipitapong S
    J Sex Med; 2021 Jul; 18(7):1299-1307. PubMed ID: 34274044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
    Scheres LJJ; Selier NLD; Nota NM; van Diemen JJK; Cannegieter SC; den Heijer M
    J Thromb Haemost; 2021 Apr; 19(4):1029-1037. PubMed ID: 33527671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Subcutaneous and Intramuscular Estradiol Regimens as Part of Gender-Affirming Hormone Therapy.
    Herndon JS; Maheshwari AK; Nippoldt TB; Carlson SJ; Davidge-Pitts CJ; Chang AY
    Endocr Pract; 2023 May; 29(5):356-361. PubMed ID: 36868378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women.
    Doll E; Gunsolus I; Thorgerson A; Tangpricha V; Lamberton N; Sarvaideo JL
    Endocr Pract; 2022 Mar; 28(3):237-242. PubMed ID: 34781041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
    Hashemi L; Marijic Buljubasic A; Budoff MJ; Copeland LA; Jackson NJ; Jasuja GK; Gornbein J; Reue K
    JAMA Netw Open; 2024 Jul; 7(7):e2419696. PubMed ID: 38954413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
    Muir CA; Guttman-Jones M; Man EJ
    Endocrine; 2024 Jul; 85(1):370-379. PubMed ID: 38386168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
    Grimstad F; Kremen J; Shim J; Charlton BM; Boskey ER
    J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):706-716. PubMed ID: 33910088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
    Cirrincione LR; Narla RR
    J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

  • 19. Examining the Influence of the Route of Administration and Dose of Estradiol on Serum Estradiol and Testosterone Levels in Feminizing Gender-Affirming Hormone Therapy.
    Slack DJ; Di Via Ioschpe A; Saturno M; Kihuwa-Mani S; Amakiri UO; Guerra D; Karim S; Safer JD
    Endocr Pract; 2024 Oct; ():. PubMed ID: 39401697
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.